NCT01472146
- Conditions
- Breast Cancer, Breast Disease, Breast Diseases, +5 more
- Locations
-
- Hospital do Cancer III - INCA Rio de Janeiro, Brazil
Clinical trial condition
Neoplasms by Site
Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.
47 public trials
16 recruiting studies
Neoplasms by Site trial results
NCT01576380
- Conditions
- Adenocarcinoma, Adenocarcinoma, Scirrhous, Carcinoma, +16 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kashiwa, Chiba, Japan
- Novartis Investigative Site Matsuyama, Ehime, Japan
- Novartis Investigative Site Sapporo, Hokkaido, Japan
NCT01629758
- Conditions
- Neoplasms, Neoplasms by Site
- Locations
-
- Oncology Research Associates, Pllc D/B/A Scottsdale, Arizona, United States
- Yale University School Of Medicine New Haven, Connecticut, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
NCT00050414
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
Not specified
Completed
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
NCT00562224
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
- Locations
-
- California Cancer Care Greenbrae, California, United States
- University of Chicago Chicago, Illinois, United States
- Sarah Cannon Research Institue Nashville, Tennessee, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00050427
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
Not specified
NCT01043913
- Conditions
- Breast Diseases, Breast Neoplasms, Fatigue, +6 more
- Locations
-
- Faculdade de Medicina do ABC Santo André, São Paulo, Brazil
NCT00377520
- Conditions
- Cancer of Endometrium, Cancer of the Endometrium, Endometrial Cancer, +15 more
- Locations
-
- Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
NCT06237920
- Conditions
- Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Rijnstate Arnhem, Gelderland, Netherlands
- Radboud University Medical Center Nijmegen, Gelderland, Netherlands
- NKI-AVL Amsterdam, North Holland, Netherlands
- Amsterdam UMC (AUMC) Amsterdam, North Holland, Netherlands
Active, Not Recruiting
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
- Research Site Iowa City, Iowa, United States